Wednesday, June 24, 2020

US Group Raises Pricing Recommendation For Gilead's Remdesivir In COVID

Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its...

from NDTV News - World-news https://ift.tt/3hX2lsF
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

"You're War Profiteer": Pro-Palestinian Employee Interrupts Microsoft AI CEO

Microsoft AI CEO Mustafa Suleyman's remarks were interrupted by a pro-Palestinian protesting employee during the technology company'...